These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 1711611)
1. Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. Wettwer E; Scholtysik G; Schaad A; Himmel H; Ravens U J Cardiovasc Pharmacol; 1991 Mar; 17(3):480-7. PubMed ID: 1711611 [TBL] [Abstract][Full Text] [Related]
2. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues. Pankucsi C; Bányász T; Magyar J; Gyönös I; Kovács A; Varró A; Szénási G; Nánási PP Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672 [TBL] [Abstract][Full Text] [Related]
3. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes. Nakaya H; Tohse N; Takeda Y; Kanno M Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298 [TBL] [Abstract][Full Text] [Related]
4. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. Sanguinetti MC; Jurkiewicz NK; Scott A; Siegl PK Circ Res; 1991 Jan; 68(1):77-84. PubMed ID: 1984874 [TBL] [Abstract][Full Text] [Related]
5. Differential effects of the new class III antiarrhythmic agents almokalant, E-4031 and D-sotalol, and of quinidine, on delayed rectifier currents in guinea pig ventricular myocytes. Wettwer E; Grundke M; Ravens U Cardiovasc Res; 1992 Nov; 26(11):1145-52. PubMed ID: 1291093 [TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent. Gwilt M; Dalrymple HW; Burges RA; Blackburn KJ; Dickinson RP; Cross PE; Higgins AJ J Cardiovasc Pharmacol; 1991 Mar; 17(3):376-85. PubMed ID: 1711597 [TBL] [Abstract][Full Text] [Related]
7. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia. MacKenzie I; Saville VL; Waterfall JF Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227 [TBL] [Abstract][Full Text] [Related]
8. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations. Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797 [TBL] [Abstract][Full Text] [Related]
9. Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium. Tande PM; Bjørnstad H; Yang T; Refsum H J Cardiovasc Pharmacol; 1990 Sep; 16(3):401-10. PubMed ID: 1700210 [TBL] [Abstract][Full Text] [Related]
11. A New Class III Antiarrhythmic Drug Niferidil Prolongs Action Potentials in Guinea Pig Atrial Myocardium via Inhibition of Rapid Delayed Rectifier. Abramochkin DV; Kuzmin VS; Rosenshtraukh LV Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):525-533. PubMed ID: 29181609 [TBL] [Abstract][Full Text] [Related]
12. Electrophysiological and mechanical effects of caffeic acid phenethyl ester, a novel cardioprotective agent with antiarrhythmic activity, in guinea-pig heart. Chang GJ; Chang CJ; Chen WJ; Yeh YH; Lee HY Eur J Pharmacol; 2013 Feb; 702(1-3):194-207. PubMed ID: 23396228 [TBL] [Abstract][Full Text] [Related]
13. KCB-328: a novel class III antiarrhythmic agent with little reverse frequency dependence in isolated guinea pig myocardium. Lee K; Lee JY; Kim HY; Kwon LS; Shin HS; Tanabe S; Kozono T; Park SD; Chung YS J Cardiovasc Pharmacol; 1998 Apr; 31(4):609-17. PubMed ID: 9554812 [TBL] [Abstract][Full Text] [Related]
14. Contribution of delayed rectifier and inward rectifier to repolarization of the action potential: pharmacologic separation. Martin CL; Chinn K J Cardiovasc Pharmacol; 1992 May; 19(5):830-7. PubMed ID: 1381782 [TBL] [Abstract][Full Text] [Related]
15. Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms. Mori K; Hara Y; Saito T; Masuda Y; Nakaya H Circulation; 1995 Jun; 91(11):2834-43. PubMed ID: 7758191 [TBL] [Abstract][Full Text] [Related]
16. Effects of TYB-3823, a new antiarrhythmic drug, on the electrophysiological properties of guinea-pig ventricular muscles. Ohmura T; Nishio M; Kigoshi S; Muramatsu I; Momose Y Gen Pharmacol; 1990; 21(4):493-7. PubMed ID: 2379802 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog. Leboeuf J; Basiez M; Massingham R Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological effects of a novel antiarrhythmic drug, EO-122, on guinea pig ventricular muscle and isolated myocytes. Binah O; Gilat E; Rubinstein I; Oppenheimer E J Cardiovasc Pharmacol; 1987 Sep; 10(3):301-8. PubMed ID: 2444778 [TBL] [Abstract][Full Text] [Related]
19. Electrophysiologic and antiarrhythmic actions of pirmenol on rabbit and guinea pig cardiac preparations. Sawanobori T; Adaniya H; Yamashita K; Kawano S; Hayami H; Kuga K; Hiraoka M J Cardiovasc Pharmacol; 1990 Dec; 16(6):975-83. PubMed ID: 1704993 [TBL] [Abstract][Full Text] [Related]
20. Effects of MDL 11,939 on action potential and contractile force in cardiac tissues: a comparison with bretylium, clofilium, and sotalol. Li T; Carr AA; Dage RC J Cardiovasc Pharmacol; 1990 Dec; 16(6):917-23. PubMed ID: 1704984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]